Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.170
+0.020 (1.74%)
At close: Oct 27, 2026, 4:00 PM EDT
1.150
-0.020 (-1.71%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $51.06 million as of October 27, 2026. It is the 29,956th most valuable company in the world and the 4,594th biggest in the United States. Its market cap has decreased by 28.26% in one year.
Market Cap
51.06M
Enterprise Value
38.59M
1-Year Change
-28.26%
Global Rank
Country Rank
#4,594 United States
Category
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $51.06M, a decrease of -59.03%. That is a compound annual growth rate of -14.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 51.06M | -58.77% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 54.65M |
| MiNK Therapeutics | 54.24M |
| Alps Group | 54.05M |
| Eloxx Pharmaceuticals | 53.85M |
| Pliant Therapeutics | 53.07M |
| Connect Biopharma Holdings | 53.06M |
| Xilio Therapeutics | 52.71M |
| Werewolf Therapeutics | 50.54M |